Meeting
2018 Gastrointestinal Cancers Symposium
COX2 and HLA immunohistochemical (IHC) staining in colorectal tumour samples from patients participating in the ASCOLT clinical trial of adjuvant aspirin therapy.
Authors
Eva Segelov
Monash University/ Monash Health, Clayton, Australia
Eva Segelov , Oliver Sieber , John Whay Kuang Chia , David S Williams
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Cancers of the Colon, Rectum, and Anus
Sub Track
Translational Research
Clinical Trial Registration Number
NCT00565708
Citation
J Clin Oncol 36, 2018 (suppl 4S; abstr 695)
DOI
10.1200/JCO.2018.36.4_suppl.695
Abstract #
695
Poster Bd #
G8
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Immunohistochemical assessment of COX2, P53, and beta-catenin expression to predict metachronous lesion development following polypectomy.
First Author: Mark Scott Johnstone
Poster
2022 ASCO Annual Meeting
Rapid access to biomarker data in a community setting: Integration of next-generation sequencing into routine pathologic workflow.
First Author: Kirstin Perdrizet
Poster
2020 Gastrointestinal Cancers Symposium
Expression of antibody-drug conjugates (ADC) biomarkers in colorectal cancer.
First Author: Sheeno P. Thyparambil
Poster
2019 ASCO Annual Meeting
Effect of exonic microsatellite instability of B2M on the predictability of MSI/dMMR for immunotherapy.
First Author: Jia Wei